CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Results of operations
- S-3 Offering Registration Statement
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
Page 6 of 10 · 198 filings